Skip to main content
. 2016 Jan 8;16(1):1–17. doi: 10.1007/s40268-015-0121-9

Fig. 1.

Fig. 1

Prominent examples of the broad array of therapeutic strategies that are showing promise for the instigation of normal expression and function of cystic fibrosis transmembrane regulator (CFTR), and their cellular targets. Ata ataluren, GP67a-pDNA lipid-enclosed DNA plasmid, Iva ivacaftor, Lum lumacaftor, ZFN zinc finger nuclease